Here are this morning’s gappers…
Potential swing trades:
See one of the recent ‘Chart Reading‘ posts for some potential swing candidates.
Potential day trades:
(From Briefing.com)
Gapping Down
INHX -57% (Veronate failed to meet primary endpoint), COR -47% (announces clinical hold on Ampakine CX717), INCY -23% (to discontinue development of DFC as treatment for HIV), RDCM -13.6% (guides Q1 revs lower), RDWR -8.5% (lowers Q1 guidance), PGIC -8.5% (reports Q4, guides FY below consensus), GTE -7.6% (reports Q4), MEDX -4.6% (announces 10 mln share offering), LVLT -4.4% (mentioned negatively in The Trader – Barron’s), CTHR -3.1%, NXXI -2.8%, SNDK -2% (Goldman downgrades to Underperform), AMD -1.7% (hearing broker downgrade), THI -1.1%.
Gapping Up
BDCO +53% (extends Friday’s 52% move), MOSS +34% (to be acquired by ICON), IPII +19% (reports Q4), RNAI +16% (forms strategic alliance with GSK), AWGI +10% (to be acquired by SCI), GEMS +8.6% (Mad Money mention), ALA +5.5% (to merge with LU), STAK +4.5%, LTON +4.7% (names C.E.O, also Susquehanna upgrade), ANX +4.2% (positive Thiovir preclinical results), ADM +4% (mentioned positively in Barron’s), TKO +4% (extends Friday’s 9% move), HLEX +3.6% (IBD mention), HOM +3.6%, BHP +3.5% (mining stocks atrong in Europe), BRCD +3.3% (teams with Ciena to extend power of Networked Storage), VTSS +3.1% (FSL selects Vitesse Gigabit ethernet switches for new platform), GM +3% (sells GMAC unit), LNUX +2.9%, MSO +2.7%, ABB +2.1% (plan to settle US claims approved — AP), NTES +2.1% (moves up on IBD 100 list), AKAM +1.9%, HANS +1.8% (target raised to $168 at Longbow), RIMM +1.8% (UBS raises tgt to $110), AMGN +1.5% (cmpletes acquisition of ABGX), MSFT +1.4% (mentioned positively in Barron’s)… Under $3: TIII +10% (reports Q4), CHTR +10% (plans refinancing), PPHM +5.8% (presents pre-clinical data).
Disclaimer & How I use this list
